Work

Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis

Year: 2017

Type: article

Source: JCO Precision Oncology

DOI: 10.1200/po.17.00032

Authors: Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, David R. Hout, Rob S. Seitz, Daniel B. Bailey, Anne P. O’Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, Priyanka Sharma

Institutions: Insight Genetics (United States), University of Kansas Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2743356669

FWCI: 0.323

Cites: 22

Cited by: 5

Related to: 10